Plexin B1 inhibits integrin-dependent pp125FAK and Rho activity in melanoma

Pigment Cell and Melanoma Research

Volumn 24, Issue 1, 2011, Pages 165-174

  McClelland, Lindy ^a   Chen, YuLin ^a   Soong, Joanne ^a   Kuo, IHsin ^a   Scott, Glynis ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Integrin; Melanoma; Plexin; Rho; Semaphorin

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE 1; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; PLEXIN; PLEXIN B1; RHO KINASE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; PROTEIN EXPRESSION;

ANIMALS; BASEMENT MEMBRANE; CATTLE; CELL LINE, TUMOR; CELL MOVEMENT; ENZYME ACTIVATION; FIBRONECTINS; FOCAL ADHESION KINASE 1; HUMANS; INTEGRINS; MELANOMA; NEOPLASM INVASIVENESS; NERVE TISSUE PROTEINS; RECEPTORS, CELL SURFACE; RHO GTP-BINDING PROTEINS;

EID: 78651420990     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2010.00797.x     Document Type: Article

References (60)

1. Akasaka, T., Van Leeuwen, R.L., Yoshinaga, I.G., Mihm, M.C. Jr, and Byers, H.R. (1995). Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol 105, 104-108.
2. Argast, G.M., Croy, C.H., Couts, K.L., Zhang, Z., Litman, E., Chan, D.C., and Ahn, N.G. (2009). Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells. Oncogene 28, 2697-2709.
3. Arnaout, M.A., Goodman, S.L., and Xiong, J.P. (2007). Structure and mechanics of integrin-based cell adhesion. Curr. Opin. Cell Biol. 19, 495-507.
4. Bagnard, D. (2001). Plexins: making links to the cytoskeleton and reducing the GAPs in our knowledge. Trends Cell Biol. 11, 107.
5. Barberis, D., Casazza, A., Sordella, R., Corso, S., Artigiani, S., Settleman, J., Comoglio, P.M., and Tamagnone, L. (2005). p190 Rho-GTPase activating protein associates with plexins and it is required for semaphorin signalling. J. Cell Sci. 118(Pt 20), 4689-4700.
6. Barry, S.T., Flinn, H.M., Humphries, M.J., Critchley, D.R., and Ridley, A.J. (1997). Requirement for Rho in integrin signalling. Cell Adhes. Commun. 4, 387-398.
7. Castellani, V., and Rougon, G. (2002). Control of semaphorin signaling. Curr. Opin. Neurobiol. 12, 532-541.
8. Conrotto, P., Corso, S., Gamberini, S., Comoglio, P.M., and Giordano, S. (2004). Interplay between scatter factor receptors and B plexins controls invasive growth. Oncogene 23, 5131-5137.
9. Dirisi, J., Penland, L., Brown, P.O., Bittner, M.L., Meltzer, P.S., Ray, M., Chen, Y., Su, Y.A., and Trent, J.M. (1996). Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14, 457-460.
10. Fujisawa, H. (2004). Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J. Neurobiol. 59, 24-33.
11. Gawecka, J.E., Griffiths, G.S., Ek-Rylander, B., Ramos, J.W., Matter, M.L. (2010). R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLos One 23, e11269.
12. Gilmore, A.P. (2005). Anoikis. Cell Death & Differen. 12(Suppl. 2), 1473-1477.
13. Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L., and Comoglio, P.M. (2002). The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat. Cell Biol. 4, 720-724.
14. Golubovskaya, V.M., Kweh, F.A., and Cance, W.G. (2009). Focal adhesion kinase and cancer. Histol. Histopathol. 24, 503-510.
15. Gomez Roman, J.J., Garay, G.O., Saenz, P. et al. (2008). Plexin B1 is downregulated in renal cell carcinomas and modulates cell growth. Transl Res 151, 134-140.
16. Halaban, R., Rubin, J.S., and White, W. (1993). met and HGF-SF in normal melanocytes and melanoma cells. Exs 65, 329-339.
17. Hall, A., Paterson, H.F., Adamson, P., and Ridley, A.J. (1993). Cellular responses regulated by rho-related small GTP-binding proteins. Philos Trans R Soc Lond B Biol Sci 340, 267-271.
18. Hanks, S.K., Ryzhova, L., Shin, N.Y., and Brabek, J. (2003). Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci 8, d982-d996.
19. Hao, H., Naomoto, Y., Bao, X. et al. (2009). Focal adhesion kinase as potential target for cancer therapy (Review). Oncol. Rep. 22, 973-979.
20. Heasman, S.J., and Ridley, A.J. (2008). Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701.
21. Hess, A.R., Postovit, L.M., Margaryan, N.V., Seftor, E.A., Schneider, G.B., Seftor, R.E., Nickoloff, B.J., and Hendrix, M.J. (2005). Focal adhesion kinase promotes the aggressive melanoma phenotype. Cancer Res. 65, 9851-9860.
22. Hotchin, N.A., and Hall, A. (1995). The assembly of integrin adhesion complexes requires both extracellular matrix and intracellular rho/rac GTPases. J. Cell Biol. 131, 1857-1865.
23. Huggins, C.E., Domenighetti, A.A., Ritchie, M.E., Khalil, N., Favaloro, J.M., Proietto, J., Smyth, G.K., Pepe, S.V., and Delbridge, L.M. (2008). Functional and metabolic remodelling in GLUT4-deficient hearts confers hyper-responsiveness to substratum intervention. J.Mol. Cell. Cardio. 44, 270-280.
24. Kahana, O., Micksche, M., Witz, I.P., and Yron, I. (2002). The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene 21, 3969-3977.
25. Kanner, S.B., Reynolds, A.B., Vines, R.R., and Parsons, J.T. (1990). Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc. Natl. Acad. Sci. U S A 87, 3328-3332.
26. Korostylev, A., Worzfeld, T., Deng, S. et al. (2008). A functional role for semaphorin 4D/plexin B1 interactions in epithelial branching morphogenesis during organogenesis. Development 135, 3333-3343.
27. Lydolph, M.C., Morgan-Fisher, M., Hoye, A.M., Couchman, J.R., Wewer, U.M., and Yoneda, A. (2009). Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage. Exp. Cell Res. 315, 3312-3324.
28. Mitra, S.K., Hanson, D.A., and Schlaepfer, D.D. (2005). Focal adhesion kinase: in command and control of cell motility. Nat. Rev. Mol. Cell Biol. 6, 56-68.
29. Moretti, S., Procopio, A., Boemi, M., and Catalano, A. (2006). Neuronal semaphorins regulate a primary immune response. Curr Neurovasc Res 3, 295-305.
30. Nakamura, F., Kalb, R.G., and Strittmatter, S.M. (2000). Molecular basis of semaphorin-mediated axon guidance. J. Neurobiol. 44, 219-229.
31. Narumiya, S., Tanji, M., and Ishizaki, T. (2009). Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev. 28, 65-76.
32. Negishi, M., Oinuma, I., and Katoh, H. (2005). Plexins: axon guidance and signal transduction. Cell. Mol. Life Sci. 62, 1363-1371.
33. Neufeld, G., Shraga-Heled, N., Lange, T., Guttmann-Raviv, N., Herzog, Y., and Kessler, O. (2005). Semaphorins in cancer. Front Biosci 10, 751-760.
34. Oinuma, I., Katoh, H., and Negishi, M. (2004). Molecular dissection of the semaphorin 4D receptor plexin-B1-stimulated R-Ras GTPase-activating protein activity and neurite remodeling in hippocampal neurons. J. Neurosci. 24, 11473-11480.
35. Oinuma, I., Katoh, H., and Negishi, M. (2006). Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating beta(1) integrin activity. J. Cell Biol. 173, 601-613.
36. Parsons, J.T., Martin, K.H., Slack, J.K., Taylor, J.M., and Weed, S.A. (2000). Focal adhesion kinase: a regulator of focal adhesion dynamics and cell movement. Oncogene 19, 5606-5613.
37. Perrot, V., Vazquez-Prado, J., and Gutkind, J.S. (2002). Plexin B regulates Rho through the guanine nucleotide exchange factors leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF. J Biol Chem 277, 43115-43120.
38. Pfaffl, M.W. (2001). A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acids Res. 29, e45.
39. Potiron, V.A., Roche, J., and Drabkin, H.A. (2009). Semaphorins and their receptors in lung cancer. Cancer Lett. 273, 1-14.
40. Reddig, P.J., and Juliano, R.L. (2005). Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev. 24, 425-439.
41. Ridley, A.J. (1997). The GTP-binding protein Rho. Int. J. Biochem. Cell Biol. 29, 1225-1229.
42. Ridley, A.J. (2001). Rho family proteins: coordinating cell responses. Trends Cell Biol. 11, 471-477.
43. Rody, A., Holtrich, U., Gaetje, R. et al. (2007). Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. Clin. Cancer Res. 13, 1115-1122.
44. Rody, A., Karn, T., Ruckhaberle, E. et al. (2009). Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis. Eur. J. Cancer 45, 405-413.
45. Routhier, A., Astuccio, M., Lahey, D. et al. (2010). Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth. Oncol. Rep. 23, 861-867.
46. Ruth, M.C., Xu, Y., Maxwell, I.H., Ahn, N.G., Norris, D.A., and Shellman, Y.G. (2006). RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. J Invest Dermatol 126, 862-868.
47. Saito, Y., Oinuma, I., Fujimoto, S., and Negishi, M. (2009). Plexin-B1 is a GTPase activating protein for M-Ras, remodelling dendrite morphology. EMBO Rep 10, 614-621.
48. Sanz-Moreno, V., and Marshall, C.J. (2009). Rho-GTPase signaling drives melanoma cell plasticity. Cell Cycle 8, 1484-1487.
49. Schena, M., Shalon, D., Heller, R., Chai, A., Brown, P.O., and Davis, R.W. (1996). Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl Acad. Sci. USA 93, 10614-10619.
50. Scott, G., and Liang, H. (1995). pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Exp. Cell Res. 219, 197-203.
51. Scott, G., Ryan, D.H., and Mccarthy, J.B. (1992). Molecular mechanisms of human melanocyte attachment to fibronectin J Invest Dermatol 99, 787-794.
52. Stevens, L., Mcclelland, L., Fricke, A., Williamson, M., Kuo, I., and Scott, G. (2010). Plexin B1 suppresses c-met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-met. J Invest Dermatol 30, 1636-1645.
53. Takaishi, K., Sasaki, T., Kato, M., Yamochi, W., Kuroda, S., Nakamura, T., Takeichi, M., and Takai, Y. (1994). Involvement of Rho p21 small GTP-binding protein and its regulator in the HGF-induced cell motility. Oncogene 9, 273-279.
54. Takegahara, N., Takamatsu, H., Toyofuku, T. et al. (2006). Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8, 615-622.
55. Tian, J., Paquette-Straub, C., Sage, E.H., Funk, S.E., Patel, V., Galileo, D., and Mclane, M.A. (2007). Inhibition of melanoma cell motility by the snake venom disintegrin eristostatin. Toxicon 50, 448-452.
56. Timar, J., Tovari, J., Szekeres, K., Kagawa, D., and Honn, K.V. (1997). Key determinants of the invasion mechanism of melanoma. Role for a new signaling pathway. Adv. Exp. Med. Biol. 407, 303-310.
57. To, C.T., and Tsao, M.S. (1998). The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review). Oncol. Rep. 5, 1013-1024.
58. Tomar, A., and Schlaepfer, D.D. (2009). Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. Curr. Opin. Cell Biol. 21, 676-683.
59. Vink, J., Thomas, L., Etoh, T., Bruijn, J.A., Mihm, M.C. Jr, Gattoni-Celli, S., and Byers, H.R. (1993). Role of beta-1 integrins in organ specific adhesion of melanoma cells in vitro. Lab. Invest. 68, 192-203.
60. Wong, O.G., Nitkunan, T., Oinuma, I. et al. (2007). Plexin-B1 mutations in prostate cancer. Proc. Natl. Acad. Sci. U S A 104, 19040-19045.